134 related articles for article (PubMed ID: 6099306)
1. Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus.
Omata T; Kohara M; Sakai Y; Kameda A; Imura N; Nomoto A
Gene; 1984 Dec; 32(1-2):1-10. PubMed ID: 6099306
[TBL] [Abstract][Full Text] [Related]
2. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine.
Kohara M; Abe S; Kuge S; Semler BL; Komatsu T; Arita M; Itoh H; Nomoto A
Virology; 1986 May; 151(1):21-30. PubMed ID: 3008430
[TBL] [Abstract][Full Text] [Related]
3. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
[TBL] [Abstract][Full Text] [Related]
4. Cloned poliovirus complementary DNA is infectious in mammalian cells.
Racaniello VR; Baltimore D
Science; 1981 Nov; 214(4523):916-9. PubMed ID: 6272391
[TBL] [Abstract][Full Text] [Related]
5. A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive.
Semler BL; Johnson VH; Tracy S
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1777-81. PubMed ID: 3006071
[TBL] [Abstract][Full Text] [Related]
6. Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals.
Semler BL; Dorner AJ; Wimmer E
Nucleic Acids Res; 1984 Jun; 12(12):5123-41. PubMed ID: 6330698
[TBL] [Abstract][Full Text] [Related]
7. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
8. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
[TBL] [Abstract][Full Text] [Related]
9. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
[TBL] [Abstract][Full Text] [Related]
10. Generation of Infectious Poliovirus with Altered Genetic Information from Cloned cDNA.
Bujaki E
Methods Mol Biol; 2016; 1387():239-49. PubMed ID: 26983738
[TBL] [Abstract][Full Text] [Related]
11. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
12. Studying poliovirus with infectious cloned cDNA.
Racaniello VR
Rev Infect Dis; 1984; 6 Suppl 2():S514-5. PubMed ID: 6330848
[TBL] [Abstract][Full Text] [Related]
13. Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2.
Pevear DC; Oh CK; Cunningham LL; Calenoff M; Jubelt B
J Gen Virol; 1990 Jan; 71 ( Pt 1)():43-52. PubMed ID: 2154539
[TBL] [Abstract][Full Text] [Related]
14. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto A; Omata T; Toyoda H; Kuge S; Horie H; Kataoka Y; Genba Y; Nakano Y; Imura N
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5793-7. PubMed ID: 6310545
[TBL] [Abstract][Full Text] [Related]
15. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
[TBL] [Abstract][Full Text] [Related]
16. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
[TBL] [Abstract][Full Text] [Related]
18. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
[TBL] [Abstract][Full Text] [Related]
19. [Construction and identification of a vector inserted with complete genome of poliovirus strain Sabin I].
Shen HH; Hou J; Hu Y; Bai BK; Wang ZJ; Yu XH; Kong W; Liu Z; Mao PY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):59-61. PubMed ID: 20848854
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
